Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Nov-24 4:30 PM View:  | Lewis-Hall Freda C Director | Conduit Pharmaceuticals Inc. (CDT) | 18-Nov-24 | Grant | 437,976 | $0.09 | $40,250.00 | 17% 2.52M to 2.96M | |
| 20-Nov-24 4:30 PM View: | Charles Faith L. Director | Conduit Pharmaceuticals Inc. (CDT) | 18-Nov-24 | Grant | 341,594 | $0.07 | $24,500.00 | 100% 0 to 341.59K | |
| 20-Nov-24 4:30 PM View: | Farley Chele Chiavacci Director | Conduit Pharmaceuticals Inc. (CDT) | 18-Nov-24 | Grant | 299,238 | $0.09 | $27,500.00 | 572% 52.27K to 351.51K | |
| 07-Oct-24 7:38 PM View: | Nirland Ltd 10% Owner | Conduit Pharmaceuticals Inc. (CDT) | 07-Oct-24 | Sale | 939,009 | $0.10 | $96,530.10 | (13%) 7.03M to 6.09M | |
| 07-Oct-24 7:38 PM View: | Nirland Ltd 10% Owner | Conduit Pharmaceuticals Inc. (CDT) | 04-Oct-24 | Sale | 1,368,990 | $0.10 | $140,458.00 | (16%) 8.4M to 7.03M | |
| 07-Oct-24 7:38 PM View: | Nirland Ltd 10% Owner | Conduit Pharmaceuticals Inc. (CDT) | 03-Oct-24 | Sale | 1,500,000 | $0.10 | $156,450.00 | (15%) 9.9M to 8.4M | |
| 02-Oct-24 5:02 PM View: | Nirland Ltd 10% Owner | Conduit Pharmaceuticals Inc. (CDT) | 02-Oct-24 | Sale | 333,177 | $0.10 | $34,250.60 | (3%) 10.23M to 9.9M | |
| 02-Oct-24 5:02 PM View: | Nirland Ltd 10% Owner | Conduit Pharmaceuticals Inc. (CDT) | 01-Oct-24 | Sale | 1,250,000 | $0.11 | $141,375.00 | (11%) 11.48M to 10.23M | |
| 02-Oct-24 5:02 PM View: | Nirland Ltd 10% Owner | Conduit Pharmaceuticals Inc. (CDT) | 30-Sep-24 | Sale | 1,016,820 | $0.12 | $122,019.00 | (8%) 12.5M to 11.48M | |
| 19-Sep-24 5:01 PM View: | Regan Andrew Director 10% Owner | Conduit Pharmaceuticals Inc. (CDT) | 17-Jul-24 | Sale | 1,514,100 | $0.26 | $391,092.00 | (9%) 17.24M to 15.72M | |
| 19-Sep-24 5:01 PM View: | Regan Andrew Director 10% Owner | Conduit Pharmaceuticals Inc. (CDT) | 16-Jul-24 | Sale | 10,244,400 | $0.32 | $3,246,450.00 | (37%) 27.48M to 17.24M | |
| 19-Sep-24 5:01 PM View: | Regan Andrew Director 10% Owner | Conduit Pharmaceuticals Inc. (CDT) | 15-Jul-24 | Sale | 1,005,200 | $0.25 | $248,385.00 | (4%) 28.49M to 27.48M | |
| 19-Sep-24 5:01 PM View: | Regan Andrew Director 10% Owner | Conduit Pharmaceuticals Inc. (CDT) | 12-Jul-24 | Sale | 1,389,820 | $0.25 | $343,425.00 | (5%) 29.88M to 28.49M | |
| 19-Sep-24 5:01 PM View: | Regan Andrew Director 10% Owner | Conduit Pharmaceuticals Inc. (CDT) | 11-Jul-24 | Sale | 882,952 | $0.29 | $260,253.00 | (3%) 30.76M to 29.88M | |
| 19-Sep-24 5:01 PM View: | Regan Andrew Director 10% Owner | Conduit Pharmaceuticals Inc. (CDT) | 10-Jul-24 | Sale | 150,000 | $0.33 | $50,070.00 | (< 1%) 30.91M to 30.76M | |
| 19-Sep-24 5:01 PM View: | Regan Andrew Director 10% Owner | Conduit Pharmaceuticals Inc. (CDT) | 09-Jul-24 | Sale | 77,681 | $0.44 | $33,853.40 | (< 1%) 30.99M to 30.91M | |
| 19-Sep-24 5:01 PM View: | Regan Andrew Director 10% Owner | Conduit Pharmaceuticals Inc. (CDT) | 08-Jul-24 | Sale | 35,923 | $0.51 | $18,320.70 | (< 1%) 31.02M to 30.99M | |
| 19-Sep-24 5:01 PM View: | Regan Andrew Director 10% Owner | Conduit Pharmaceuticals Inc. (CDT) | 03-Jul-24 | Sale | 1,000 | $0.64 | $640.00 | (< 1%) 31.02M to 31.02M | |
| 19-Sep-24 5:01 PM View: | Regan Andrew Director 10% Owner | Conduit Pharmaceuticals Inc. (CDT) | 14-Jun-24 | Acquisition (other) | 1,100,000 | -- | -- | 4% 31.02M to 32.12M | |
| 19-Sep-24 5:01 PM View: | Regan Andrew Director 10% Owner | Conduit Pharmaceuticals Inc. (CDT) | 14-Jun-24 | Disposition (other) | 1,100,000 | -- | -- | (3%) 32.12M to 31.02M | |
| 11-Jun-24 5:56 PM View: | Farley Chele Chiavacci Director | Conduit Pharmaceuticals Inc. (CDT) | 11-Jun-24 | Grant | 37,272 | -- | -- | 248% 15.0K to 52.27K | |
| 11-Jun-24 5:53 PM View: | Bligh James Interim CFO Director | Conduit Pharmaceuticals Inc. (CDT) | 11-Jun-24 | Grant | 37,272 | -- | -- | 100% 0 to 37.27K | |
| 15-May-24 4:30 PM View: | Sragovicz Adam Chief Financial Officer | Conduit Pharmaceuticals Inc. (CDT) | 15-May-24 | Disposition | 74,545 | -- | -- | (100%) 74.55K to 0 | |
| 05-Dec-23 5:20 PM View: | Sragovicz Adam Chief Financial Officer | Conduit Pharmaceuticals Inc. (CDT) | 01-Dec-23 | Grant | 74,545 | -- | -- | 100% 0 to 74.55K | |
| 26-Sep-23 5:49 PM View: | Farley Chele Chiavacci Director | Conduit Pharmaceuticals Inc. (CDT) | 22-Sep-23 | Grant | 15,000 | -- | -- | 100% 0 to 15.0K | |
| 26-Sep-23 5:30 PM View: | Heilbron Jack Kendrick | Conduit Pharmaceuticals Inc. (CDT) | 22-Sep-23 | Disposition (other) | 45,000 | -- | -- | (1%) 4.06M to 4.02M | |
| 26-Sep-23 5:30 PM View: | Heilbron Jack Kendrick | Conduit Pharmaceuticals Inc. (CDT) | 22-Sep-23 | Option Exercise | 4,060,250 | -- | -- | 100% 0 to 4.06M |
